Trademark: 90760541
Status Date
Monday, March 4, 2024
Filing Date
Tuesday, June 8, 2021
Published for Opposition
Tuesday, April 12, 2022
5 Pharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, immunological and inflammatory related diseases and disorders; pharmaceutical preparations for the treatment of complement-mediated neurological diseases and disorders; none of the foregoing being pharmaceutical preparations for the treatment of sialorrhea
Apr 11, 2024
Teas Change Of Correspondence Received
Apr 11, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 11, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 3 Granted
Mar 4, 2024
Sou Extension 3 Filed
Mar 4, 2024
Sou Teas Extension Received
Sep 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2023
Sou Extension 2 Granted
Sep 6, 2023
Sou Extension 2 Filed
Sep 6, 2023
Sou Teas Extension Received
Mar 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 10, 2023
Sou Extension 1 Granted
Mar 10, 2023
Sou Extension 1 Filed
Mar 10, 2023
Sou Teas Extension Received
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 21, 2022
Extension Of Time To Oppose Process - Terminated
Aug 16, 2022
Changes/Corrections After Pub Approval Entered
Aug 15, 2022
Assigned To Petition Staff
Jul 29, 2022
Teas Post Publication Amendment Received
May 6, 2022
Extension Of Time To Oppose Received
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 7, 2022
Approved For Pub - Principal Register
Feb 25, 2022
Assigned To Examiner
Aug 28, 2021
New Application Office Supplied Data Entered
Jun 11, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
